Beam Therapeutics Inc.BEAMNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank88
3Y CAGR+0.5%
5Y CAGR+25.1%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+0.5%/yr
vs +74.2%/yr prior
5Y CAGR
+25.1%/yr
Recent deceleration
Acceleration
-73.7pp
Decelerating
Percentile
P88
Within normal range
vs 5Y Ago
3.1x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $316.01M | -14.0% |
| 2024 | $367.56M | - |
| 2023 | $0.00 | -100.0% |
| 2022 | $311.59M | +34.2% |
| 2021 | $232.13M | +125.0% |
| 2020 | $103.18M | +88.9% |
| 2019 | $54.62M | +61.2% |
| 2018 | $33.87M | - |
| 2017 | $0.00 | - |